Hypothalamus-adipose tissue crosstalk: Neuropeptide y and the regulation of energy metabolism

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  Zhang, Wei ^a   Cline, Mark A ^a   Gilbert, Elizabeth R ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Adipose tissue; Hypothalamus; neuropeptide Y; Obesity; Sympathetic nervous system; Thermogenesis

Indexed keywords

NEUROPEPTIDE Y;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADRENERGIC SYSTEM; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENERGY BALANCE; ENERGY METABOLISM; FEEDBACK SYSTEM; HUMAN; HYPOTHALAMUS; INNERVATION; LIPID STORAGE; LIPOLYSIS; NERVOUS SYSTEM; NONHUMAN; REVIEW; SYMPATHETIC NERVE; THERMOGENESIS; TISSUE DISTRIBUTION; WHITE ADIPOSE TISSUE;

MAMMALIA;

EID: 84903395955     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-11-27     Document Type: Review

References (86)

1. Central nervous system control of food intake and body weight. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW, Nature 2006 443 289 295
2. Adipocytes as regulators of energy balance and glucose homeostasis. Rosen ED, Spiegelman BM, Nature 2006 444 847 853
3. The role of NPY in hypothalamic mediated food intake. Mercer RE, Chee MJ, Colmers WF, Front Neuroendocrinol 2011 32 398 415
4. A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide. Carlquist M, Jornvall H, Tatemoto K, Mutt V, Gastroenterology 1982 83 245 249
5. New and emerging drug molecules against obesity. George M, Rajaram M, Shanmugam E, J Cardiovasc Pharmacol Ther 2014 19 65 76
6. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T, Proc Natl Acad Sci U S A 1998 95 15043 15048
7. Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Kohno D, Yada T, Neuropeptides 2012 46 315 319
8. Hypothalamic control of energy balance: different peptides, different functions. Leibowitz SF, Wortley KE, Peptides 2004 25 473 504
9. Evolution of neuropeptide Y and its related peptides. Larhammar D, Blomqvist AG, Soderberg C, Comp Biochem Physiol C 1993 106 743 752
10. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Naveilhan P, Neveu I, Arenas E, Ernfors P, Neuroscience 1998 87 289 302
11. Role of hypothalamic neuropeptide Y in feeding and obesity. Gehlert DR, Neuropeptides 1999 33 329 338
12. Gut hormone PYY(3-36) physiologically inhibits food intake. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR, Nature 2002 418 650 654
13. Neuropeptide y receptor selective ligands in the treatment of obesity. Kamiji MM, Inui A, Endocr Rev 2007 28 664 684
14. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Labelle M, Boulanger Y, Fournier A, St Pierre S, Savard R, Peptides 1997 18 801 808
15. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M, Fukuroda T, Am J Physiol 1998 274 1500 R1504
16. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. Kanatani A, Ishihara A, Asahi S, Tanaka T, Ozaki S, Ihara M, Endocrinology 1996 137 3177 3182
17. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. Mullins D, Kirby D, Hwa J, Guzzi M, Rivier J, Parker E, Mol Pharmacol 2001 60 534 540
18. Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. Burcelin R, Brunner H, Seydoux J, Thorensa B, Pedrazzini T, Peptides 2001 22 421 427
19. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M, Nakamura M, Proc Natl Acad Sci U S A 1998 95 15659 15664
20. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Balasubramaniam A, Joshi R, Su C, Friend LA, James JH, Peptides 2007 28 235 240
21. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H, Proc Natl Acad Sci U S A 2002 99 8938 8943
22. Y4 receptor knockout rescues fertility in ob/ob mice. Sainsbury A, Schwarzer C, Couzens M, Jenkins A, Oakes SR, Ormandy CJ, Herzog H, Genes Dev 2002 16 1077 1088
23. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG, Diabetes 1997 46 1792 1798
24. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y. Tang-Christensen M, Kristensen P, Stidsen CE, Brand CL, Larsen PJ, J Endocrinol 1998 159 307 312
25. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD, Nat Med 1998 4 718 721
26. NPY and stress 30 years later: the peripheral view. Hirsch D, Zukowska Z, Cell Mol Neurobiol 2012 32 645 659
27. Central Y4 receptor distribution. Radioactive ribonucleotide probe in situ hybridization with in vitro receptor autoradiography. Larsen PJ, Kristensen P, Methods Mol Biol 2000 153 185 198
28. Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. Lin S, Shi YC, Yulyaningsih E, Aljanova A, Zhang L, Macia L, Nguyen AD, Lin EJ, During MJ, Herzog H, Sainsbury A, PLoS One 2009 4 8488
29. Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation. Singer K, Morris DL, Oatmen KE, Wang T, DelProposto J, Mergian T, Cho KW, Lumeng CN, PLoS One 2013 8 57929
30. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z, Nat Med 2007 13 803 811
31. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Kos K, Harte AL, James S, Snead DR, O'Hare JP, McTernan PG, Kumar S, Am J Physiol Endocrinol Metab 2007 293 1335 E1340
32. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors. Sitticharoon C, Chatree S, Churintaraphan M, Regul Pept 2013 185 65 72
33. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. Yang K, Guan H, Arany E, Hill DJ, Cao X, FASEB J 2008 22 2452 2464
34. Quantity of glucose transporter and appetite-associated factor mRNA in various tissues after insulin injection in chickens selected for low or high body weight. Zhang W, Sumners LH, Siegel PB, Cline MA, Gilbert ER, Physiol Genomics 2013 45 1084 1094
35. Lipolysis and apoptosis of adipocytes induced by neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides in obese rats. Gong HX, Guo XR, Fei L, Guo M, Liu QQ, Chen RH, Acta Pharmacol Sin 2003 24 569 575
36. Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes. Rosmaninho-Salgado J, Cortez V, Estrada M, Santana MM, Goncalves A, Marques AP, Cavadas C, Neuropeptides 2012 46 359 366
37. Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line. Gericke MT, Kosacka J, Koch D, Nowicki M, Schroder T, Ricken AM, Nieber K, Spanel-Borowski K, Br J Pharmacol 2009 157 620 632
38. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. Sethi JK, Vidal-Puig AJ, J Lipid Res 2007 48 1253 1262
39. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak LP, J Clin Invest 1995 96 2914 2923
40. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS, Nature 1993 366 740 742
41. Unexpected evidence for active brown adipose tissue in adult humans. Nedergaard J, Bengtsson T, Cannon B, Am J Physiol Endocrinol Metab 2007 293 444 E452
42. Identification and importance of brown adipose tissue in adult humans. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR, N Engl J Med 2009 360 1509 1517
43. Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function. Kirkland JL, Dobson DE, J Am Geriatr Soc 1997 45 959 967
44. Cross-talk between sympathetic neurons and adipocytes in coculture. Turtzo LC, Marx R, Lane MD, Proc Natl Acad Sci U S A 2001 98 12385 12390
45. Cotransmission from sympathetic vasoconstrictor neurons to small cutaneous arteries in vivo. Morris JL, Am J Physiol 1999 277 58 H64
46. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Lundberg JM, Franco-Cereceda A, Hemsen A, Lacroix JS, Pernow J, Fundam Clin Pharmacol 1990 4 373 391
47. Brain-adipose tissue cross talk. Bartness TJ, Kay Song C, Shi H, Bowers RR, Foster MT, Proc Nutr Soc 2005 64 53 64
48. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-gamma expression. Rosmaninho-Salgado J, Marques AP, Estrada M, Santana M, Cortez V, Grouzmann E, Cavadas C, Peptides 2012 37 49 54
49. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes. Bradley RL, Mansfield JP, Maratos-Flier E, Obes Res 2005 13 653 661
50. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnansky R, Zukowska Z, Ann N Y Acad Sci 2008 1148 232 237
51. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Shi YC, Lin S, Castillo L, Aljanova A, Enriquez RF, Nguyen AD, Baldock PA, Zhang L, Bijker MS, Macia L, Yulyaningsih E, Zhang H, Lau J, Sainsbury A, Herzog H, Obesity (Silver Spring) 2011 19 2137 2148
52. The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance. Baker SB, Cohen M, Kuo L, Johnson M, Al-Attar A, Zukowska Z, Plast Reconstr Surg 2009 123 486 492
53. Central Sympathetic Innervations to Visceral and Subcutaneous White Adipose Tissue. Nguyen NL, Randall J, Banfield BW, Bartness TJ, Am J Physiol Regul Integr Comp Physiol 2014 306 375 386
54. Neuropeptide Y potentiates beta-adrenergic stimulation of lipolysis in 3 T3-L1 adipocytes. Li R, Guan H, Yang K, Regul Pept 2012 178 16 20
55. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. Valet P, Berlan M, Beauville M, Crampes F, Montastruc JL, Lafontan M, J Clin Invest 1990 85 291 295
56. Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes. Castan I, Valet P, Quideau N, Voisin T, Ambid L, Laburthe M, Lafontan M, Carpene C, Am J Physiol 1994 266 1141 R1147
57. The biology of white adipocyte proliferation. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ, Obes Rev 2001 2 239 254
58. Obesity-a state of reduced sympathetic activity and normal or high adrenal activity (the autonomic and adrenal hypothesis revisited). Bray GA, Int J Obes 1990 14 Suppl 3 77 91 discussion 91-72
59. Sympathetic but not sensory denervation stimulates white adipocyte proliferation. Foster MT, Bartness TJ, Am J Physiol Regul Integr Comp Physiol 2006 291 1630 R1637
60. Role of sympathetic innervation in brown adipocyte proliferation. Geloen A, Collet AJ, Bukowiecki LJ, Am J Physiol 1992 263 1176 R1181
61. Monoclonal antibodies against cell surface antigens expressed during porcine adipocyte differentiation. Wright JT, Hausman GJ, Int J Obes 1990 14 395 409
62. Adipocyte development is dependent upon stem cell recruitment and proliferation of preadipocytes. Kras KM, Hausman DB, Hausman GJ, Martin RJ, Obes Res 1999 7 491 497
63. Increased alpha 2-adrenergic binding sites and antilipolytic effect in adipocytes from genetically obese rats. Carpene C, Rebourcet MC, Guichard C, Lafontan M, Lavau M, J Lipid Res 1990 31 811 819
64. Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system. Han R, Kitlinska JB, Munday WR, Gallicano GI, Zukowska Z, PLoS One 2012 7 36609
65. Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue. Bartness TJ, Song CK, J Lipid Res 2007 48 1655 1672
66. Innervation of brown adipose tissue and its role in thermogenesis. Bartness TJ, Song CK, Canadian Journal of Diabetes 2005 29 9
67. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Billington CJ, Briggs JE, Grace M, Levine AS, Am J Physiol 1991 260 321 R327
68. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Chao PT, Yang L, Aja S, Moran TH, Bi S, Cell Metab 2011 13 573 583
69. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Shi YC, Lau J, Lin Z, Zhang H, Zhai L, Sperk G, Heilbronn R, Mietzsch M, Weger S, Huang XF, Enriquez RF, Baldock PA, Zhang L, Sainsbury A, Herzog H, Lin S, Cell Metab 2013 17 236 248
70. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Egawa M, Yoshimatsu H, Bray GA, Am J Physiol 1991 260 328 R334
71. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Altarejos JY, Montminy M, Nat Rev Mol Cell Biol 2011 12 141 151
72. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS, Am J Physiol Gastrointest Liver Physiol 2007 293 1 G4
73. Brown adipose tissue: recent insights into development, metabolic function and therapeutic potential. Townsend K, Tseng YH, Adipocyte 2012 1 13 24
74. Liu Y, Neural Crosstalk between Sympathetic Nervous System and Sensory Circuits to Brown Adipose Tissue, Thesis Department of Biology: Georgia State University 2013 1 35
75. Brain-adipose tissue neural crosstalk. Bartness TJ, Song CK, Physiol Behav 2007 91 343 351
76. Dual innervation of white adipose tissue: some evidence for parasympathetic nervous system involvement. Bartness TJ, J Clin Invest 2002 110 1235 1237
77. Anterograde transneuronal viral tract tracing reveals central sensory circuits from white adipose tissue. Song CK, Schwartz GJ, Bartness TJ, Am J Physiol Regul Integr Comp Physiol 2009 296 501 R511
78. Long-term sensory denervation by neonatal capsaicin treatment augments sympathetic neurotransmission in rat mesenteric arteries by increasing levels of norepinephrine and selectively enhancing postjunctional actions. Ralevic V, Karoon P, Burnstock G, J Pharmacol Exp Ther 1995 274 64 71
79. Brain-gut-adipose-tissue communication pathways at a glance. Yi CX, Tschop MH, Dis Model Mech 2012 5 583 587
80. Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Yamada T, Katagiri H, Ishigaki Y, Ogihara T, Imai J, Uno K, Hasegawa Y, Gao J, Ishihara H, Niijima A, Mano H, Aburatani H, Asano T, Oka Y, Cell Metab 2006 3 223 229
81. Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe. Baker DG, Bertram TM, Patel PM, Barkauskas DA, Clopton P, Patel S, Geracioti TD Jr, Haji U, O'Connor DT, Nievergelt CM, Hauger RL, Psychoneuroendocrinology 2013 38 2378 2382
82. Sibutramine therapy in obese women-effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations. Baranowska B, Wolinska-Witort E, Martynska L, Chmielowska M, Mazurczak-Pluta T, Boguradzka A, Baranowska-Bik A, Neuro Endocrinol Lett 2005 26 675 679
83. Nonsaturable entry of neuropeptide Y into brain. Kastin AJ, Akerstrom V, Am J Physiol 1999 276 479 E482
84. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man. Ahlborg G, Weitzberg E, Sollevi A, Lundberg JM, Acta Physiol Scand 1992 145 139 149
85. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses. Zhang K, Rao F, Miramontes-Gonzalez JP, Hightower CM, Vaught B, Chen Y, Greenwood TA, Schork AJ, Wang L, Mahata M, Stridsberg M, Khandrika S, Biswas N, Fung MM, Waalen J, Middelberg RP, Heath AC, Montgomery GW, Martin NG, Whitfield JB, Baker DG, Schork NJ, Nievergelt CM, O'Connor DT, J Am Coll Cardiol 2012 60 1678 1689
86. Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research. Berrettini WH, Oxenstierna G, Sedvall G, Nurnberger JI Jr, Gold PW, Rubinow DR, Goldin LR, Psychiatry Res 1988 25 349 359